[Effect of ascorbic acid on the formation of excess amounts of p-hydroxyphenyllactic acid in lymphosarcoma].
D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006713:Homogentisic Acid / Q000378:metabolism; D006801:Humans; D007773:Lactates / Q000378:metabolism*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D010666:Phenylpropionates / Q000378:metabolism*; D010667:Phenylpyruvic Acids / Q000378:metabolism; D013997:Time Factors; D014443:Tyrosine / Q000378:metabolism
D007773:Lactates; D010666:Phenylpropionates; D010667:Phenylpyruvic Acids; D014443:Tyrosine; D006713:Homogentisic Acid; D001205:Ascorbic Acid
Vliianie askorbinovoĭ kisloty na obrazovanie izbytochnykh kolichestv p-oksifenilmolochnoĭ kisloty u bol'nykh limforsarkomami.